Search Results - "Boulton, Craig"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study by Boulton, Craig, Meiser, Karin, David, Olivier J., Schmouder, Robert

    Published in Journal of clinical pharmacology (01-12-2012)
    “…Fingolimod, a first-in-class oral sphingosine 1-phosphate receptor (S1PR) modulator, is approved in many countries for relapsing-remitting multiple sclerosis,…”
    Get full text
    Journal Article
  2. 2

    Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma by Boulton, Craig, David, Olivier J., Meiser, Karin, Schmouder, Robert

    Published in Clinical pharmacology in drug development (01-01-2013)
    “…Fingolimod, a first‐in‐class sphingosine 1‐phosphate receptor modulator, is the first approved oral therapy for relapsing multiple sclerosis (MS). While…”
    Get full text
    Journal Article
  3. 3